Canaan XI L.P.

Canaan XI L.P. discloses dealings in 2 companies, chiefly Day One Biopharmaceuticals, Inc. and Tyra Biosciences, Inc. Over a trading history stretching from 1 June 2021 to 21 September 2022, the count stands at 7 filings.

Every open-market trade on record is a sale: 3 sales worth €16.0M. So far in 2022, the count stands at no purchases and 3 sales.

The newest entry dates from 22 September 2022: an open-market sale of €11.5M, in Day One Biopharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.